{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:54:16Z","timestamp":1791006856106,"version":"4.1.0"},"reference-count":28,"publisher":"Biomedical Research Press","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2026,9,20]]},"DOI":"10.2220\/biomedres.47.191","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:12:11Z","timestamp":1790460731000},"page":"191-202","source":"Crossref","is-referenced-by-count":0,"title":["Poly-(A)-binding protein cytoplasmic 1 gene regulates cell proliferation via TP53 R273H hotspot activation in Japanese patients with common cancer types"],"prefix":"10.2220","volume":"47","author":[{"given":"Shumpei","family":"OHNAMI","sequence":"first","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"MARUYAMA","sequence":"additional","affiliation":[{"name":"Experimental Animal Facility"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"NAGASHIMA","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"},{"name":"SRL Inc, Minato-ku, Tokyo 107-0052, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"OHNAMI","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"HATAKEYAMA","sequence":"additional","affiliation":[{"name":"Multiomics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"WATANABE","sequence":"additional","affiliation":[{"name":"Medical Genetics Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"OHSHIMA","sequence":"additional","affiliation":[{"name":"Medical Genetics Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"TAKAHASHI","sequence":"additional","affiliation":[{"name":"Experimental Animal Facility"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"MIZUGUCHI","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"SUGIYAMA","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukumi","family":"KAMADA","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sou","family":"NAKATANI","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"SHIMODA","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"URAKAMI","sequence":"additional","affiliation":[{"name":"Cancer Diagnostics Research Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"SHIOMI","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"YAMAGUCHI","sequence":"additional","affiliation":[{"name":"Shizuoka Cancer Center, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1059","reference":[{"key":"1","unstructured":"Alexandrov LB, Kim J and Haradhvala NJ (2020) The repertoire of mutational signatures in human cancer. <i>Nature<\/i> <b>578<\/b>, 94\u2013 101."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bieging KT, Mello SS and Attardi LD (2014) Unravelling mechanisms of p53-mediated tumour suppression. <i>Nat Rev Cancer<\/i> <b>14<\/b>, 359\u2013370.","DOI":"10.1038\/nrc3711"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Brady CA, Jiang D and Mello SS (2011) Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. <i>Cell<\/i> <b>145<\/b>, 571\u2013583.","DOI":"10.1016\/j.cell.2011.03.035"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Brown CJ, Lain S, Verma CS, Fersht AR and Lane DP (2009) Awakening guardian angels: drugging the p53 pathway. <i>Nat Rev Cancer<\/i> <b>9<\/b>, 862\u2013873.","DOI":"10.1038\/nrc2763"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chiang YT, Chien YC, Lin YH, Wu HH, Lee DF, <i>et al.<\/i> (2021) The function of the mutant p53-R175H in cancer. <i>Cancers<\/i> <b>13<\/b>, 4088.","DOI":"10.3390\/cancers13164088"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, <i>et al.<\/i> (2019) Integrated analysis of TP53 gene and pathway alterations in The Cancer Genome Atlas. <i>Cell Rep<\/i> <b>28<\/b>, 1370\u2013 1384.","DOI":"10.1016\/j.celrep.2019.07.001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Duffy MJ, Synnott NC, O\u2019Grady S and Crown J (2022) Targeting p53 for the treatment of cancer. <i>Semin Cancer Biol<\/i> <b>79<\/b>, 58\u2013 67.","DOI":"10.1016\/j.semcancer.2020.07.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hu J, Cao J, Topatana W, Juengpanich S, Li S, <i>et al.<\/i> (2021) Targeting mutant p53 for cancer therapy: direct and indirect strategies. <i>J Hematol Oncol<\/i> <b>14<\/b>, 157.","DOI":"10.1186\/s13045-021-01169-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Kajjo S, Sharma S, Chen S, Brothers WR, Cott M, <i>et al.<\/i> (2022) PABP prevents the untimely decay of select mRNA populations in human cells. <i>EMBO J<\/i> <b>41<\/b>, e108650.","DOI":"10.15252\/embj.2021108650"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kato S, Han SY, Liu W, Otsuka K, Shibata H, <i>et al.<\/i> (2003) Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA <b>100<\/b>, 8424\u20138429.","DOI":"10.1073\/pnas.1431692100"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Khoo KH, Verma CS and Lane DP (2014) Drugging the p53 pathway: understanding the route to clinical efficacy. <i>Nat Rev Drug Discov<\/i> <b>13<\/b>, 217\u2013236.","DOI":"10.1038\/nrd4236"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Koyama T, Shimizu T, Kojima Y, Sudo K, Okuma HS, <i>et al.<\/i> (2023) Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase Ib\/II study. <i>Cancer Discov<\/i> <b>13<\/b>, 1814\u20131825.","DOI":"10.1158\/2159-8290.CD-23-0419"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Levine AJ (2020) p53: 800 million years of evolution and 40 years of discovery. <i>Nat Rev Cancer<\/i> <b>20<\/b>, 471\u2013480.","DOI":"10.1038\/s41568-020-0262-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Liu Y, Su Z, Tavana O and Gu W (2024) Understanding the complexity of p53 in a new era of tumor suppression. <i>Cancer Cell<\/i> <b>42<\/b>, 946\u2013967.","DOI":"10.1016\/j.ccell.2024.04.009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Meng X, Xiao W, Sun J, Li W, Yuan H, <i>et al.<\/i> (2023) CircPTK2\/ PABPC1\/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer. <i>Cancer Lett<\/i> <b>554<\/b>, 216023.","DOI":"10.1016\/j.canlet.2022.216023"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, <i>et al.<\/i> (2020) Japanese version of the cancer genome atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients. <i>Cancer Sci<\/i> <b>111<\/b>, 687\u2013699.","DOI":"10.1111\/cas.14290"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ohnami S, Maruyama K, Chen K, Takahashi Y, Hatakeyama K, <i>et al.<\/i> (2021) <i>BMP4<\/i> and <i>PHLDA1<\/i> are plausible drug-targetable candidate genes for <i>KRAS<\/i> G12A-, G12D-, and G12V-driven colorectal cancer. <i>Mol Cell Biochem<\/i> <b>476<\/b>, 3469\u20133482.","DOI":"10.1007\/s11010-021-04172-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ohnami S, Ohshima K, Nagashima T, Urakami K, Shimoda Y, <i>et al.<\/i> (2017) Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors. <i>Mol Cell Biochem<\/i> <b>431<\/b>, 75\u201385.","DOI":"10.1007\/s11010-017-2977-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ohshima K, Hatakeyama K, Nagashima T, Watanabe Y, Kanto K, <i>et al.<\/i> (2017) Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. <i>Sci Rep<\/i> <b>7<\/b>, 641.","DOI":"10.1038\/s41598-017-00219-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Peuget S, Zhou X and Selivanova G (2024) Translating p53-based therapies for cancer into the clinic. <i>Nat Rev Cancer<\/i> <b>24<\/b>, 192\u2013215.","DOI":"10.1038\/s41568-023-00658-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Soussi T and Wiman KG (2015) TP53: an oncogene in disguise. <i>Cell Death Differ<\/i> <b>22<\/b>, 1239\u20131249.","DOI":"10.1038\/cdd.2015.53"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Stracquadanio G, Wang X, Wallace M, Grawenda AM, Zhang P, <i>et al.<\/i> (2016) The importance of p53 pathway genetics in inherited and somatic cancer genomes. <i>Nat Rev Cancer<\/i> <b>16<\/b>, 251\u2013265.","DOI":"10.1038\/nrc.2016.15"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Tuval A, Strandgren C, Heldin A, Palomar-Siles M and Wiman KG (2024) Pharmacological reactivation of p53 in the era of precision anticancer medicine. <i>Nat Rev Clin Oncol<\/i> <b>21<\/b>, 106\u2013 120.","DOI":"10.1038\/s41571-023-00842-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz Jr LA, <i>et al.<\/i> (2013) Cancer genome landscapes. <i>Science<\/i> <b>339<\/b>, 1546\u20131558.","DOI":"10.1126\/science.1235122"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Wang Z, Burigotto M, Ghetti S, Vaillant F, Tan T, <i>et al.<\/i> (2024) Loss-of-function but not gain-of-function properties of mutant TP53 are critical for the proliferation, survival, and metastasis of a broad range of cancer cells. <i>Cancer Discov<\/i> <b>14<\/b>, 362\u2013379.","DOI":"10.1158\/2159-8290.CD-23-0402"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Yamaguchi K, Urakami K, Nagashima T, Shimoda Y, Ohnami S, <i>et al.<\/i> (2016) Prevalence of low-penetrant germline <i>TP53<\/i> D49H mutation in Japanese cancer patients. <i>Biomedical Res (Tokyo)<\/i> <b>37<\/b>, 259\u2013264.","DOI":"10.2220\/biomedres.37.259"},{"key":"27","doi-asserted-by":"crossref","unstructured":"YuFeng Z and Ming Q (2020) Expression and prognostic roles of PABPC1 in hepatocellular carcinoma. <i>Int J Surg<\/i> <b>84<\/b>, 3\u201312.","DOI":"10.1016\/j.ijsu.2020.10.004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Qi Y, Wang M and Jiang Q (2022) PABPC1\u2014mRNA stability, protein translation and tumorigenesis. Front Oncol 12, 1025291.","DOI":"10.3389\/fonc.2022.1025291"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/47\/5\/47_191\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:24:08Z","timestamp":1791005048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/47\/5\/47_191\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.47.191","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]}}}